Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs CBRE✓SelectedUSD · CBREGSK vs CBRE performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs CBRE

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+64.4%
CBRE return
+69.3%
Excess return
-5.0%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioCBREExcessAlpha
1D-0.1%0.0%-0.1%-0.1%
7D-1.3%-3.6%+2.3%-0.7%
30D+2.7%+0.1%+2.7%+2.7%
3M+2.7%-12.9%+15.6%+4.9%
6M+3.3%+2.5%+0.9%+2.9%
YTD+6.5%-17.2%+23.6%+8.7%
1Y+10.7%-13.3%+24.0%+12.2%
3Y+64.4%+70.6%-6.3%+52.9%
All+64.4%+69.3%-5.0%+52.9%

Cumulative growth

Daily Returns

Daily percentage return beside CBRE.

Daily Out/Under-Performance

Portfolio return minus CBRE return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CBRE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded CBRE wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling